Literature DB >> 28045493

Inhalation and Oropharyngeal Aspiration Exposure to Rod-Like Carbon Nanotubes Induce Similar Airway Inflammation and Biological Responses in Mouse Lungs.

Pia Kinaret, Marit Ilves, Vittorio Fortino, Elina Rydman1, Piia Karisola, Anna Lähde2, Joonas Koivisto3, Jorma Jokiniemi2, Henrik Wolff1, Kai Savolainen1, Dario Greco, Harri Alenius4.   

Abstract

Carbon nanotubes (CNTs) have the potential to impact technological and industrial progress, but their production and use may, in some cases, cause serious health problems. Certain rod-shaped multiwalled CNTs (rCNTs) can, in fact, induce severe asbestos-like pathogenicity in mice, including granuloma formation, fibrosis, and even cancer. Evaluating the comparability between alternative hazard assessment methods is needed to ensure fast and reliable evaluation of the potentially adverse effects of these materials. To compare two alternative airway exposure methods, C57BL/6 mice were exposed to rCNTs by a state-of-the-art but laborious and expensive inhalation method (6.2-8.2 mg/m3, 4 h/day for 4 days) or by oropharyngeal aspiration (10 or 40 μg/day for 4 days), which is cheaper and easier to perform. In addition to histological and cytological studies, transcriptome analysis was also carried out on the lung tissue samples. Both inhalation and low-dose (10 μg/day) aspiration exposure to rCNTs promoted strong accumulation of eosinophils in the lungs and recruited also a few neutrophils and lymphocytes. In contrast, the aspiration of a high-dose (40 μg/day) rCNT caused only a mild pulmonary eosinophilia but enhanced accumulation of neutrophils in the airways. Inhalation and low-dose aspiration exposure promoted comparable giant cell formation, mucus production, and IL-13 expression in the lungs. Both exposure methods also exacerbated similar expression alterations with 154 (56.4%) differentially expressed, overlapping genes in microarray analyses. Of all differentially expressed genes, up to 80% of the activated biological functions were shared according to pathway enrichment analyses. Inhalation and low-dose aspiration elicited very similar pulmonary inflammation providing evidence that oropharyngeal aspiration is a valid approach and a convenient alternative to the inhalation exposure for the hazard assessment of nanomaterials.

Entities:  

Keywords:  allergic airway inflammation; aspiration; carbon nanotubes; immune system; inflammation; inhalation; transcriptomics

Mesh:

Substances:

Year:  2017        PMID: 28045493     DOI: 10.1021/acsnano.6b05652

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  22 in total

1.  Genetic determinants of susceptibility to silver nanoparticle-induced acute lung inflammation in mice.

Authors:  David K Scoville; Dianne Botta; Karen Galdanes; Stefanie C Schmuck; Collin C White; Patricia L Stapleton; Theo K Bammler; James W MacDonald; William A Altemeier; Michelle Hernandez; Steven R Kleeberger; Lung-Chi Chen; Terry Gordon; Terrance J Kavanagh
Journal:  FASEB J       Date:  2017-07-17       Impact factor: 5.191

2.  Inhalation exposure to multi-walled carbon nanotubes alters the pulmonary allergic response of mice to house dust mite allergen.

Authors:  Mark D Ihrie; Alexia J Taylor-Just; Nigel J Walker; Matthew D Stout; Amit Gupta; Jamie S Richey; Barry K Hayden; Gregory L Baker; Barney R Sparrow; Katherine S Duke; James C Bonner
Journal:  Inhal Toxicol       Date:  2019-07-26       Impact factor: 2.724

3.  Manually curated transcriptomics data collection for toxicogenomic assessment of engineered nanomaterials.

Authors:  Laura Aliisa Saarimäki; Antonio Federico; Iseult Lynch; Anastasios G Papadiamantis; Andreas Tsoumanis; Georgia Melagraki; Antreas Afantitis; Angela Serra; Dario Greco
Journal:  Sci Data       Date:  2021-02-08       Impact factor: 6.444

Review 4.  Nanotechnology in Transportation Vehicles: An Overview of Its Applications, Environmental, Health and Safety Concerns.

Authors:  Muhammad Shafique; Xiaowei Luo
Journal:  Materials (Basel)       Date:  2019-08-06       Impact factor: 3.623

5.  Multinucleated giant cell phenotype in response to stimulation.

Authors:  Kevin L Trout; Andrij Holian
Journal:  Immunobiology       Date:  2020-05-05       Impact factor: 3.144

6.  Toxicogenomic Profiling of 28 Nanomaterials in Mouse Airways.

Authors:  Pia A S Kinaret; Joseph Ndika; Marit Ilves; Henrik Wolff; Gerard Vales; Hannu Norppa; Kai Savolainen; Tiina Skoog; Juha Kere; Sergio Moya; Richard D Handy; Piia Karisola; Bengt Fadeel; Dario Greco; Harri Alenius
Journal:  Adv Sci (Weinh)       Date:  2021-03-08       Impact factor: 16.806

7.  Mine-site derived particulate matter exposure exacerbates neurological and pulmonary inflammatory outcomes in an autoimmune mouse model.

Authors:  Alexis Wilson; Carmen A Velasco; Guy W Herbert; Selita N Lucas; Bethany N Sanchez; José M Cerrato; Michael Spilde; Quan-Zhen Li; Matthew J Campen; Katherine E Zychowski
Journal:  J Toxicol Environ Health A       Date:  2021-03-07

8.  Macrophage sensing of single-walled carbon nanotubes via Toll-like receptors.

Authors:  Sourav P Mukherjee; Olesja Bondarenko; Pekka Kohonen; Fernando T Andón; Táňa Brzicová; Isabel Gessner; Sanjay Mathur; Massimo Bottini; Paolo Calligari; Lorenzo Stella; Elena Kisin; Anna Shvedova; Reija Autio; Heli Salminen-Mankonen; Riitta Lahesmaa; Bengt Fadeel
Journal:  Sci Rep       Date:  2018-01-18       Impact factor: 4.379

9.  Pulmonary exposure to carbonaceous nanomaterials and sperm quality.

Authors:  Astrid Skovmand; Anna Jacobsen Lauvås; Preben Christensen; Ulla Vogel; Karin Sørig Hougaard; Sandra Goericke-Pesch
Journal:  Part Fibre Toxicol       Date:  2018-01-31       Impact factor: 9.400

10.  Substantial modification of the gene expression profile following exposure of macrophages to welding-related nanoparticles.

Authors:  Étienne Audureau; Angélique Simon-Deckers; Marie-Laure Franco-Montoya; Balasubramanyam Annangi; Ali Kermanizadeh; Jorge Boczkowski; Sophie Lanone
Journal:  Sci Rep       Date:  2018-06-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.